breast cancer

A free e-book by researchers at Washington University School of Medicine provides practical, science-based advice for lowering breast cancer risk at every stage of life. “Together — Every Woman’s Guide to Preventing Breast Cancer” is written for a lay audience to help women improve their breast health and the breast health of their loved ones.

​William Gillanders, MD, a physician-scientist and avid cyclist, keeps the wheels turning in the race against breast cancer. His career goal is to change treatment paradigms by making breast cancer vaccines a reality for those being treated for the disease.

A breast cancer vaccine developed at the School of Medicine is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence from the small clinical trial, led by William Gillanders, MD, also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression.

People at high risk for psychological distress respond positively to receiving results of personalized genetic testing, according to new research at Washington University School of Medicine in St. Louis. More than 60 percent of subjects in the genetic study wanted information about their test results, and 95 percent said they appreciated receiving the information, regardless of whether the results were good or bad news.

In recognition of National Breast Cancer Awareness Month, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine​ in St. Louis shares eight ways women can lower their risk of breast cancer. 

Washington University’s Global Health Center selected five ​WUSTL students for its inaugural summer research program, which paired students with faculty mentors to explore issues such as malnutrition, maternal health and access to health care. Pictured is program participant Laura Bliss, a second-year medical student.

Washington University’s Bear Cub program is funding four innovative projects that have commercial potential. Pictured is William G. Hawkins, MD, who is developing a new treatment for pancreatic cancer.

The Journal of Biological Chemistry has recognized School of Medicine researcher Ron Bose, MD, PhD, and his colleagues for work describing the combined structure of two proteins that, when bound together, drive growth of many breast cancers.

Patients who experience ‘chemobrain’ following treatment for breast cancer show disruptions in brain networks that are not present in patients who do not report cognitive difficulties, according to School of Medicine researchers.

Human breast tumors transplanted into mice are excellent models of metastatic cancer and are providing insights into how to attack breast cancers that no longer respond to the drugs used to treat them, according to research led by Matthew J. Ellis, MD, PhD, from Washington University School of Medicine in St. Louis.